Andrea Di Fonzo

The paper designs a high-affinity CLDN5 peptide binder, ST9, that induces reversible, size-controlled BBB openings without altering CLDN5 expression or proteomic profile.

This study identifies synergistic microRNAs that suppress glioblastoma progression by targeting key pathways and genes associated with tumor growth and poor prognosis.

This study shows that CaMKIV phosphorylation of REST at Ser-322 reduces its repressor activity and promotes its degradation.

This study evaluates miRNA-based therapy for medulloblastoma using a xenotransplant model, showing reduced tumor growth and invasiveness through miRNA restoration.